Navigation Links
Kendle Delivers Strong Growth in Revenues, New Business Authorizations and Operating Margin for Full-Year 2007; Announces Guidance for 2008
Date:2/27/2008

tion related to acquired intangibles, expenses related to the acquisition of CRLCS and an $8.2 million impairment charge on a customer relationship asset. Excluding these items net income per diluted share for fourth quarter 2006 was $0.14 per diluted share.

Income from operations for fourth quarter 2007 was approximately $15.2 million, or 14.6 percent of net service revenues, compared to a loss of approximately $1.8 million in fourth quarter 2006. Net income was approximately $6.4 million in fourth quarter 2007 compared to a loss of $4.7 million in the fourth quarter of 2006. Net service revenues by geographic region for the fourth quarter of 2007 were 50 percent in North America, 40 percent in Europe, 6 percent in Latin America and 4 percent in the Asia/Pacific region. The top five customers based on net service revenues accounted for 29 percent of net service revenues for fourth quarter 2007 compared to 26 percent of net service revenues for fourth quarter 2006.

New business awards were $174 million for fourth quarter 2007, which represents a 6 percent increase over the same quarter last year. Contract cancellations for the quarter were approximately $32 million. Total business authorizations amounted to $869 million at Dec. 31, 2007, up 5 percent from Sept. 30, 2007, and an all-time Company high.

"2007 was a year of significant growth for Kendle highlighted by record backlog and a strong increase in revenues and operating margin," said Candace Kendle, PharmD, Chairman and Chief Executive Officer. "Demonstrating our continued focus on project delivery and operational excellence in support of our customers' clinical development goals, we grew above the market for the fourth consecutive year. In particular, our increased scale and competitiveness in winning and executing megatrials was a significant contributor to our success and positions us well to deliver improved earnings and profitability for our shareholders as we move forward."

Re
'/>"/>

SOURCE Kendle International Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Kendle Invites You to Attend Its Fourth Quarter and Year End 2007 Earnings Conference Call and Webcast
2. Kendle Appoints Industry Veteran to Lead Asia/Pacific Expansion
3. Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007
4. Kendle Appoints Ken Hintze, PhD, Vice President, Global Clinical Safety & Pharmacovigilance
5. Kendle Executive Dennis Hurley, DrSc to Present Keynote Address at DIA Latin American Congress 2007
6. Norton Healthcare Delivers Information to the Point-of-Care with EMC Information Infrastructure
7. AT&T Delivers Benefits of RFID Inventory Tracking to Health First
8. Leading National Patient Advocacy Group Delivers Warning to U.S. Patients: Having Health Insurance Does NOT Mean Your Medical Needs Will Be Covered
9. Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year
10. Liquent Insight Publisher 3.6 Delivers Advanced Submission Capabilities
11. March of Dimes Delivers a New Look
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... (May 18, 2013) A ground-breaking advance in ... according to research presented today at Digestive Disease ... minimal withdrawal time for colonoscopies and exploring safer ... colonoscopy, doctors use a device called a colonoscope ... colorectal cancer allows a doctor to look for ...
(Date:5/18/2013)... York (PRWEB) May 18, 2013 ... mesh products continue to move forward in a consolidated ... Bernstein Liebhard LLP reports. According to a notice on ... the Ethicon pelvic mesh litigation will be held on ... complaints have been filed in the proceeding on behalf ...
(Date:5/18/2013)... HealthDay Reporter , , FRIDAY, May 17 (HealthDay News) -- It ... but new research shows that college women are more likely ... than are college men. Much of this difference ... on a weekly basis is much lower for women than ... for men. But, there,s good reason for that difference. Women ...
(Date:5/18/2013)... After working diligently for months and putting in a ... integration of the fitment specs for the redesigned 2012 Hyundai ... the automobile market with its extraordinary features and unique combination ... the latest entry in the size it up ... year 2013. , Aptly suiting its name, 2012 Hyundai ...
(Date:5/18/2013)... DC (PRWEB) May 18, 2013 Family Magazine ... designation for excellence by Follow Media Consulting, Inc. in the ... signifies the continued commitment and dedication of the areas best ... , No one knows parenting better than Brenda Hyde, a ... is to help parents know about the vast resources available ...
Breaking Medicine News(10 mins):Health News:New colonoscope provides ground-breaking view of colon 2Health News:New colonoscope provides ground-breaking view of colon 3Health News:New colonoscope provides ground-breaking view of colon 4Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 2Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 3Health News:College Women More Prone to Problem Drinking Than Men: Study 2Health News:College Women More Prone to Problem Drinking Than Men: Study 3Health News:Renowned Rim Fitments Provider SizeItUp Launched Database Integrations for the 2012 Hyundai Genesis 2Health News:Summer Camps in DC "Best of the Best" Awarded to Family Magazine of Washington DC for Excellence by Follow Media Consulting, Inc. 2
... -- Alcohol use by American teens has dropped to historic ... believe it,s a dangerous drug, according to an annual national ... and the University of Michigan. The nationally representative survey ... 400 public and private schools found a continuing trend of ...
... GURGAON, Delhi (NCR), India -- Vishwa Mohan Katoch, M.D., ... India: Future Directions" at the AACR International Conference on ... Therapy, Dec. 13-16, 2011, in Gurgaon, Delhi (NCR), India. ... India Department of Health Research and director-general of the ...
... cancers worldwide. Kaposi,s sarcoma herpesvirus (KSHV) is an etiological ... lymphoproliferative malignancies. KS is the most common cancer in ... cancer deaths in many subequatorial African countries as a ... of Biotechnology and Research Programs Unit (Genome-Scale Biology) at ...
... and the Management Sciences (INFORMS) today announced the award ... Medal to Dr. Don N. Kleinmuntz, President and co-founder ... web-based financial analytics and performance management software tools used ... their financial planning, budgeting, and reporting processes. , ...
... News) --,A new study finds that two out of ... hands. Researchers gave seven scenarios to 85 third-year ... asked them to identify which of the situations required ... correctly identified the five scenarios that required hand hygiene: ...
... conducted by researchers at Boston University School of Medicine ... house dust extract (HDE) causes pulmonary inflammation that aggravates ... PhD, professor of pathology, was published in the December ... and was selected by the editorial board as the ...
Cached Medicine News:Health News:Alcohol Use Down, Pot Use Up Among U.S. Teens 2Health News:KS-herpesvirus induces reprogramming of lymphatic endothelial cells to invasive mesenchymal cells 2Health News:INFORMS presents Ramsey Medal to health care financial analytics executive Don Kleinmuntz 2
(Date:5/17/2013)... 2013  Boehringer Ingelheim will contribute to advancing ... American Thoracic Society International Conference (ATS 2013) in ... – 22. Data will highlight research ... of chronic obstructive pulmonary disease (COPD) [Spiriva® HandiHaler® ... compounds for asthma, idiopathic pulmonary fibrosis (IPF) and ...
(Date:5/17/2013)... 2013 Oramed Pharmaceuticals Inc. (NASDAQCM: ... delivery systems, announced today that the United States Food ... New Drug application(IND) for ORMD-0801, its oral insulin capsule. ... FDA clearance to proceed," stated Nadav Kidron ... a major milestone for Oramed and we look forward ...
(Date:5/16/2013)... CHICAGO, Ill. and MECHELEN, Belgium ... (Euronext: GLPG) and AbbVie (NYSE: ABBV ) ... collaboration to include Crohn,s disease.  Galapagos will fund and ... is designed to facilitate rapid progression into Phase 3.  ... 2015, AbbVie will pay Galapagos $50 million.  The terms ...
Breaking Medicine Technology:Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 2Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 3Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 4Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 5Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 6Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 7Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 8Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6
... couples to create page on Pinktimeline.com to receive £50 ... have launched a fundraising resource on their website, http://www.pinktimeline.com ... for associated costs. Couples can create a private fundraising page ... raise funds for specialty consultations, fertility treatments or even to ...
... 25, 2011 INNOPHARMA LLC announced today FDA approval of ... generic equivalent of Zyprexa® injection). As the developer ... with Sandoz Inc., pursuant to which Sandoz will sell, market ... About INNOPHARMA: INNOPHARMA is ...
Cached Medicine Technology:First Response Launches IVF Fundraising Resource for Those Trying for a Baby 2First Response Launches IVF Fundraising Resource for Those Trying for a Baby 3
... an automated microplate analyzer capable ... techniques. Open architecture design makes ... manufacturers' microplate assays and provides ... and I.F.A. methods as well ...
... Micro Plate Processor is a precise, ... Analyzer. It has been designed for ... can be customised according to the ... Processor is able to process automatically ...
The GEM OPL CO-Oximeter provides comprehensive oxygenation status in an easy-to-use, portable manner. The GEM OPL is the ideal solution for laboratory or point-of-care CO-Oximetry testing....
The Maxi-Therm® lite hyper-hypothermia water blankets from Cincinnati Sub-Zero take conductive warming and cooling therapy to a new, softer level. These blankets are soft, lightweight, and remai...
Medicine Products: